Endovascular Revascularisation: When and How
Critical limb ischaemia in diabetic patients is associated with significant morbidity and mortality. The incidence of peripheral vascular disease is much higher amongst the diabetic population and associated diabetic neuropathy often means patients present late with ulceration and tissue loss. Management of the diabetic foot requires a multi-disciplinary team approach. Timely initiation of the appropriate investigations and treatment are vital to ensure optimal outcomes. Revascularisation can be performed with open bypass surgery or endovascular repair. There is increasing evidence to support endovascular treatment and with the gradual evolution of endovascular technologies it is now possible to effectively treat complex patterns of disease. In this chapter we will further explore the imaging assessment and the available endovascular treatment options in diabetic patients.
KeywordsDiabetes Peripheral arterial disease Critical limb ischaemia Endovascular revascularisation Angioplasty Angiosome
- 3.Norgren L, Hiatt WR, Dormandy JR, Nehler MR, Harris KA, Fowkes FG, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5–67.Google Scholar
- 7.Laird JR, Katzen BT, Scheinery D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation vs balloon angioplasty for lesions in the SFA and proximal popliteal arteries of patients with claudication: three year follow up from RESILIENT randomized trial. J Endovasc Ther. 2012;19(1):1–9.PubMedCrossRefGoogle Scholar
- 8.Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2 year follow up from the Zilver PTX randomized and single arm clinical studies. J Am Coll Cardiol. 2013;61(24):2417–27.PubMedCrossRefGoogle Scholar